Form D · Other
Autolus Therapeutics plc
London, X0 · CIK 0001730463
Offering snapshot reported Feb 23, 2024 · SEC filing
- Reported sold
- $200M Offering amount: $200M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 23, 2024 | Initial | $200,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-506008
Source: Form D, filed Feb 23, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Anderson | Director |
| Robert Azelby | Director |
| Linda Bain | Director |
| John Berriman | Director |
| Edgar Braendle | Executive |
| David Brochu | Executive |
| Cynthia Butitta | Director |
| Robert Dolski | Executive |
| Robert Iannone | Director |
| Christian Itin | Director, Executive |
| John H. Johnson | Director |
| Elisabeth Leiderman | Director |
| Martin Murphy | Director |
| Martin Pule | Executive |
| Brent Rice | Executive |
| Christopher Vann | Executive |
| William D. Young | Director |
Issuer details
Industry: Other (See others in industry)
Address:
C/O Media Works 191 Wood Lane
London, X0, W12 7FP
London, X0, W12 7FP